AIM Explained: The UK's Small-Cap Market Navigating a Critical Transition

The Alternative Investment Market is at a crossroads. A tax change taking effect in April 2026 is removing one of the incentives that drew long-term investors to UK small-cap stocks for decades, and the number of companies listed on AIM has already fallen to its lowest point in more than twenty years. Yet the market continues to offer something genuinely rare: a regulated public listing route for businesses too small or too early-stage for the main London Stock Exchange.

Understanding what AIM is, how it works, and where it stands today matters more now than it did a few years ago.

Note: this article covers the UK market specifically.

A Market Built for Growth Companies

AIM has no minimum requirements on revenue, profitability, or trading history. A company does not need to be UK-based. What it does need is a Nominated Adviser, known as a NOMAD, and a genuine commitment to meeting the market's ongoing rules. That accessibility is the point. AIM was designed to give businesses public capital before they are ready for the scrutiny and cost of the main market.

The types of companies that find a home on AIM reflect that open-door approach. Biotech firms burning through cash while awaiting trial results. Mining companies with promising assets but no production revenue yet. Technology businesses with strong growth but thin margins. Family-owned companies seeking outside capital for the first time. For each of these, the main LSE would be out of reach. AIM is not.

For some companies it becomes a permanent listing venue. For others it is an intermediate stage. Abcam, the life sciences business that became a global leader in research antibodies, built its credibility and investor base on AIM before eventually outgrowing it. ASOS joined in 2001 with a market cap below £15 million and spent two decades on AIM before moving to the LSE Main Market in February 2022, by which point its market cap had climbed to nearly £5 billion.

Past performance does not guarantee future results. Nothing in this article constitutes investment advice.

The IHT Change That Is Reshaping the Investor Case

For many years, one of AIM's most compelling features for a certain type of investor had nothing to do with growth potential. AIM-listed shares held for at least two years qualified for full Business Property Relief, making them completely exempt from inheritance tax. That made AIM a legitimate estate planning tool, drawing in patient, long-term capital that benefited both investors and the companies they backed.

The October 2024 Budget ended that arrangement. From 6 April 2026, the full exemption is replaced by partial relief, with an effective inheritance tax rate of 20% on AIM-held shares. The change does not eliminate the relief entirely, but it removes the zero-rate advantage that made AIM ISA portfolios particularly attractive to wealthier, longer-horizon investors.

This is not a peripheral detail. It is one of the primary reasons the listed company count on AIM has been falling, and it shifts the investor calculus in a way that will take time to fully play out.

How AIM Fits Into the London Stock Exchange Group

A point that regularly causes confusion: AIM is not related to "alternative investments" in the financial sense. The term usually refers to asset classes like hedge funds, private equity, or collectibles. AIM is simply a sub-market within the London Stock Exchange group. The name reflects its purpose as an alternative listing route, not a different asset class.

Both AIM and the LSE Main Market sit under the same parent organisation, but they operate under meaningfully different rules and attract very different companies.

A structural feature that sits behind all of this is AIM's reliance on self-regulation through NOMADs rather than direct regulatory oversight. NOMADs are firms approved by the exchange that take legal responsibility for assessing a company's readiness to list, preparing its admission document, and ensuring continued compliance once trading begins. Removing a NOMAD from a listed company is one of the most serious sanctions available under AIM's rules.

Investors wanting index-level exposure rather than individual stock selection can access the market through the FTSE AIM All-Share Index, the FTSE AIM 100 Index, or the FTSE AIM UK 50 Index.

Getting Listed on AIM: How the Process Works

The admission process is more demanding than AIM's lighter-touch reputation sometimes implies. A company begins by appointing a NOMAD, which then takes responsibility for assembling and coordinating the wider advisory team: typically a broker, legal counsel, and an auditing firm.

That team produces the AIM admission document, a detailed disclosure covering the company's business model, financial history, management, and forward plans. Unlike on the main market, this document is not submitted to the FCA. The NOMAD owns the scrutiny process. That places considerable weight on the NOMAD relationship, which is also why losing a NOMAD post-admission is treated as a serious event.

AIM sets no hard thresholds on size or profitability, but a company must demonstrate that its governance structures are appropriate, its leadership is capable, and its strategy is credible. It must also formally commit to the market's rules before trading begins.

From first NOMAD appointment to listing typically takes a few months. Once shares are trading publicly, the company takes on ongoing obligations: regular financial reporting and prompt disclosure of any material developments that could affect its share price.

AIM's Track Record: What the Numbers and the Stories Show

AIM launched in June 1995 with ten listed companies, created by the LSE as a successor to the Unlisted Securities Market. Its original purpose was to open a regulated route to public capital for businesses that the main market could not accommodate. That purpose has not changed.

By 2024 the market's figures told a story of both scale and pressure.

Source: London Stock Exchange

The post-IPO performance figure and the capital raised point to a market that still functions. The falling company count points to structural pressures that are real and ongoing.

Several companies that listed on AIM went on to become significant names in their sectors. Fever-Tree joined in 2014 and grew into one of the UK's most recognised premium drinks brands on the back of strong international sales. Jet2 built its position as a leading UK travel and holiday operator from its AIM listing. Hutchmed developed an oncology drug pipeline using capital raised on the market. Boohoo expanded its online fashion business internationally. Each of these companies used AIM to access public investment at a stage when the main market was not a realistic option.

What AIM Offers Now, and What Has Changed

AIM was once described as the world's most successful growth market. That characterisation reflected a period of consistent expansion in listed company numbers, active international participation, and an investor base attracted by both growth potential and tax efficiency.

That picture has shifted. Higher compliance costs, tighter standards, and the removal of full IHT exemption from 2026 have each contributed to a shrinking listed population. The market is smaller and under more pressure than it was a decade ago.

What has not changed is its function. AIM remains the only venue in the UK that offers a regulated public listing to companies at the earliest stages of their development, without imposing size or history requirements. For investors who understand that smaller companies carry greater risk, who are prepared to research individual businesses carefully, and who take a patient approach, the market continues to offer exposure to growth opportunities that the main market simply does not provide.